Heider, K., Kiefer, K., Zenz, T., Volden, M., Stilgenbauer, S., Ostermann, E., . . . Borges, E. (2011). A novel Fc-engineered monoclonal antibody to CD37 with enhanced ADCC and high proapoptotic activity for treatment of B-cell malignancies. American Society of Hematology.
Citación estilo ChicagoHeider, Karl-Heinz, et al. A Novel Fc-engineered Monoclonal Antibody to CD37 With Enhanced ADCC and High Proapoptotic Activity for Treatment of B-cell Malignancies. American Society of Hematology, 2011.
Cita MLAHeider, Karl-Heinz, et al. A Novel Fc-engineered Monoclonal Antibody to CD37 With Enhanced ADCC and High Proapoptotic Activity for Treatment of B-cell Malignancies. American Society of Hematology, 2011.
Precaución: Estas citas no son 100% exactas.